Qualitative EEG shows promise in Identifying Mild DLB

Dementia is often preceded by an earlier phase called mild cognitive impairment (MCI), where an individual is still able to live independently, but notices changes in at least one area […]
Read More

Rate of Dementia Diagnosis Varies by Clinician Type and Patient Race/Ethnicity

With an aging population and life expectancies on the rise, the number of people with dementia in the U.S. is projected to reach nearly 12 million in 20 years. However, […]
Read More

Research

New Report – Lewy Body Dementia: State of the Science We are entering an era of unprecedented opportunity for understanding and treating Lewy body dementia (LBD). Our newest white paper, […]
Read More

Research Advance: DLB Genetics Uniquely Different from Parkinson’s

The human genome is a complete set of a person’s DNA. Serving as a blueprint for all cells in the body, the genome contains about 20,000 genes. The first human […]
Read More

Scientific Advance: Diagnosing LBD in Living Persons

An LBD research advance by scientists at the National Institutes of Health (NIH) is making headlines. Using a procedure called a lumbar puncture (or spinal tap), researchers diagnosed two Lewy […]
Read More

Shifting into Virtual Mode for LBD Research Meetings

In February of 2020 B.C. (before COVID-19), LBDA planned to host/attend 3 day-long meetings related to LBD research in June in Cleveland, OH. And then the pandemic hit. So, we […]
Read More

Sleep Disorder Increases Odds of DLB by Five Times Over Alzheimer’s

REM sleep behavior disorder (RBD) is a condition that causes a person to physically act out their dreams and is a common in Lewy body dementia (LBD). RBD is a […]
Read More

Symptoms Differ in Alzheimer’s when Lewy Bodies are Present

Lewy body pathology (presence of Lewy bodies in the brain)  is found in up to 50% of cases of late-onset Alzheimer’s disease, which can make it challenging for physicians to […]
Read More

Treatment

Download this article as a PDF The importance of early treatment is supported by recent data suggesting that patients with LBD, might respond better to cholinesterase inhibitors than patients with […]
Read More

Treatment Study Halted Early Because of Promising Results

With all the recent news about failed clinical trials for disease-modifying treatments for Alzheimer’s disease, a little encouraging news is timely. ACADIA Pharmaceuticals announced an early end to one of […]
Read More